title: [Comparative study of indoramin versus dihydroergotamine in the preventive treatment of migraine].
authors.forename: A
authors.initials: A
authors.lastname: Pradalier
authors.forename: J
authors.initials: J
authors.lastname: Dry
authors.forename: B
authors.initials: B
authors.lastname: Loisy
authors.forename: V
authors.initials: V
authors.lastname: Meininger
authors.forename: E
authors.initials: E
authors.lastname: Vicaut
authors.forename: C
authors.initials: C
authors.lastname: Mirabaud
authors.forename: M
authors.initials: M
authors.lastname: Levy
mesh_terms: D000328:Adult; D002986:Clinical Trials as Topic; D004087:Dihydroergotamine / Q000009:adverse effects / Q000627:therapeutic use*; D004311:Double-Blind Method; D004341:Drug Evaluation; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D007217:Indoramin / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D008881:Migraine Disorders / Q000517:prevention & control*; D013997:Time Factors
chemical_list: D007211:Indoles; D007217:Indoramin; D004087:Dihydroergotamine
vernacular_title: Etude comparative indoramine versus dihydroergotamine dans le traitement préventif de la migraine.